Exact Mass: 423.2443

Exact Mass Matches: 423.2443

Found 60 metabolites which its exact mass value is equals to given mass value 423.2443, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Militarinone C

Militarinone C

C26H33NO4 (423.2409)


   

LysoPE(14:1(9Z)/0:0)

(2-aminoethoxy)[(2R)-2-hydroxy-3-[(9Z)-tetradec-9-enoyloxy]propoxy]phosphinic acid

C19H38NO7P (423.2386)


LysoPE(14:1(9Z)/0:0) is a lysophosphatidylethanolamine or a lysophospholipid. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic however it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Some LPLs serve important signaling functions such as lysophosphatidic acid. Lysophosphatidylethanolamines (LPEs) can function as plant growth regulators with several diverse uses. (LPEs) are approved for outdoor agricultural use to accelerate ripening and improve the quality of fresh produce. They are also approved for indoor use to preserve stored crops and commercial cut flowers. As a breakdown product of phosphatidylethanolamine (PE), LPE is present in cells of all organisms. [HMDB] LysoPE(14:1(9Z)/0:0) is a lysophosphatidylethanolamine or a lysophospholipid. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic however it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Some LPLs serve important signaling functions such as lysophosphatidic acid. Lysophosphatidylethanolamines (LPEs) can function as plant growth regulators with several diverse uses. (LPEs) are approved for outdoor agricultural use to accelerate ripening and improve the quality of fresh produce. They are also approved for indoor use to preserve stored crops and commercial cut flowers. As a breakdown product of phosphatidylethanolamine (PE), LPE is present in cells of all organisms.

   

LysoPE(0:0/14:1(9Z))

(2-aminoethoxy)[(2R)-3-hydroxy-2-[(9Z)-tetradec-9-enoyloxy]propoxy]phosphinic acid

C19H38NO7P (423.2386)


LysoPE(0:0/14:1(9Z)) is a lysophosphatidylethanolamine or a lysophospholipid. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic however it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Some LPLs serve important signaling functions such as lysophosphatidic acid. Lysophosphatidylethanolamines (LPEs) can function as plant growth regulators with several diverse uses. (LPEs) are approved for outdoor agricultural use to accelerate ripening and improve the quality of fresh produce. They are also approved for indoor use to preserve stored crops and commercial cut flowers. As a breakdown product of phosphatidylethanolamine (PE), LPE is present in cells of all organisms. [HMDB] LysoPE(0:0/14:1(9Z)) is a lysophosphatidylethanolamine or a lysophospholipid. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic however it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Some LPLs serve important signaling functions such as lysophosphatidic acid. Lysophosphatidylethanolamines (LPEs) can function as plant growth regulators with several diverse uses. (LPEs) are approved for outdoor agricultural use to accelerate ripening and improve the quality of fresh produce. They are also approved for indoor use to preserve stored crops and commercial cut flowers. As a breakdown product of phosphatidylethanolamine (PE), LPE is present in cells of all organisms.

   

2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-

5-{5-[(piperazin-1-yl)methyl]-1,3,4-oxadiazol-2-yl}-N4-propyl-N2-[2-(pyridin-4-yl)ethyl]pyrimidine-2,4-diamine

C21H29N9O (423.2495)


   
   
   

Dideoxymalyngamide C

Dideoxymalyngamide C

C24H38ClNO3 (423.254)


   

sonneratine A

sonneratine A

C26H33NO4 (423.2409)


   
   

L-Valyl-L-amiclenomycyl-L-glutamine|Valylamiclenomycylglutamine

L-Valyl-L-amiclenomycyl-L-glutamine|Valylamiclenomycylglutamine

C20H33N5O5 (423.2482)


   

brevicompanine E

brevicompanine E

C25H33N3O3 (423.2522)


   

N-Palmitoyl-L-serine phosphoric acid

N-Palmitoyl-L-serine phosphoric acid

C19H38NO7P (423.2386)


   

LPE(14:1)

1-Myristoleoyl-2-hydroxy-sn-glycero-3-phosphoethanolamine

C19H38NO7P (423.2386)


   

PE(14:1(9Z)/0:0)

1-(9Z-tetradecenoyl)-glycero-3-phosphoethanolamine

C19H38NO7P (423.2386)


   

LPE 14:1

2-(9Z-tetradecenoyl)-sn-glycero-3-phosphoethanolamine

C19H38NO7P (423.2386)


   

8H-Indeno[1,2-d]oxazole, 2-[2,2-bis[(4S)-4,5-dihydro-4-(1-methylethyl)-2-oxazolyl]propyl]-3a,8a-dihydro-, (3aS,8aR)

8H-Indeno[1,2-d]oxazole, 2-[2,2-bis[(4S)-4,5-dihydro-4-(1-methylethyl)-2-oxazolyl]propyl]-3a,8a-dihydro-, (3aS,8aR)

C25H33N3O3 (423.2522)


   

Fmoc-11-aminoundecanoic acid

Fmoc-11-aminoundecanoic acid

C26H33NO4 (423.2409)


   

Cyprenorphine

Cyprenorphine

C26H33NO4 (423.2409)


D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist

   
   

N-butyl-3-{[6-(9H-purin-6-ylamino)hexanoyl]amino}benzamide

N-butyl-3-{[6-(9H-purin-6-ylamino)hexanoyl]amino}benzamide

C22H29N7O2 (423.2383)


   

(3R,5R)-7-[(1S,2S,6R,8S,8aR)-6-hydroxy-2-methyl-8-[(2S)-2-methylbutanoyl]oxy-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoate

(3R,5R)-7-[(1S,2S,6R,8S,8aR)-6-hydroxy-2-methyl-8-[(2S)-2-methylbutanoyl]oxy-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoate

C23H35O7- (423.2383)


   

a 1-acyl-sn-glycero-3-phosphoethanolamine (n-C14:1)

a 1-acyl-sn-glycero-3-phosphoethanolamine (n-C14:1)

C19H38NO7P (423.2386)


   

a 2-acyl-sn-glycero-3-phosphoethanolamine (n-C14:1)

a 2-acyl-sn-glycero-3-phosphoethanolamine (n-C14:1)

C19H38NO7P (423.2386)


   

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] tetradec-7-enoate

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] tetradec-7-enoate

C19H38NO7P (423.2386)


   

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-hydroxypropan-2-yl] (E)-tetradec-7-enoate

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-hydroxypropan-2-yl] (E)-tetradec-7-enoate

C19H38NO7P (423.2386)


   

Pravachol

Pravachol

C23H35O7- (423.2383)


D057847 - Lipid Regulating Agents > D000960 - Hypolipidemic Agents > D000924 - Anticholesteremic Agents D004791 - Enzyme Inhibitors > D019161 - Hydroxymethylglutaryl-CoA Reductase Inhibitors D009676 - Noxae > D000963 - Antimetabolites

   

4-butoxy-N-[4-[4-(2-methyl-1-oxopropyl)-1-piperazinyl]phenyl]benzamide

4-butoxy-N-[4-[4-(2-methyl-1-oxopropyl)-1-piperazinyl]phenyl]benzamide

C25H33N3O3 (423.2522)


   

(6S,7S,8S)-7-[4-(3-cyclopentylprop-1-ynyl)phenyl]-8-(hydroxymethyl)-2-oxo-N-propyl-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

(6S,7S,8S)-7-[4-(3-cyclopentylprop-1-ynyl)phenyl]-8-(hydroxymethyl)-2-oxo-N-propyl-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

C25H33N3O3 (423.2522)


   

(6R,7R,8S)-7-[4-(3-cyclopentylprop-1-ynyl)phenyl]-8-(hydroxymethyl)-2-oxo-N-propyl-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

(6R,7R,8S)-7-[4-(3-cyclopentylprop-1-ynyl)phenyl]-8-(hydroxymethyl)-2-oxo-N-propyl-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

C25H33N3O3 (423.2522)


   

(6S,7S,8R)-7-[4-(3-cyclopentylprop-1-ynyl)phenyl]-8-(hydroxymethyl)-2-oxo-N-propyl-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

(6S,7S,8R)-7-[4-(3-cyclopentylprop-1-ynyl)phenyl]-8-(hydroxymethyl)-2-oxo-N-propyl-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

C25H33N3O3 (423.2522)


   

2-cyclopropyl-1-[(1R)-2-(cyclopropylmethyl)-1-(hydroxymethyl)-7-methoxy-9-methyl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]yl]ethanone

2-cyclopropyl-1-[(1R)-2-(cyclopropylmethyl)-1-(hydroxymethyl)-7-methoxy-9-methyl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]yl]ethanone

C25H33N3O3 (423.2522)


   

(6R,7R,8R)-N-cyclopentyl-8-(hydroxymethyl)-7-[4-(4-methylpent-1-ynyl)phenyl]-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

(6R,7R,8R)-N-cyclopentyl-8-(hydroxymethyl)-7-[4-(4-methylpent-1-ynyl)phenyl]-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

C25H33N3O3 (423.2522)


   

(6S,7R,8S)-7-[4-(3-cyclopentylprop-1-ynyl)phenyl]-8-(hydroxymethyl)-2-oxo-N-propyl-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

(6S,7R,8S)-7-[4-(3-cyclopentylprop-1-ynyl)phenyl]-8-(hydroxymethyl)-2-oxo-N-propyl-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

C25H33N3O3 (423.2522)


   

(6R,7S,8S)-7-[4-(3-cyclopentylprop-1-ynyl)phenyl]-8-(hydroxymethyl)-2-oxo-N-propyl-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

(6R,7S,8S)-7-[4-(3-cyclopentylprop-1-ynyl)phenyl]-8-(hydroxymethyl)-2-oxo-N-propyl-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

C25H33N3O3 (423.2522)


   

(6R,7S,8R)-7-[4-(3-cyclopentylprop-1-ynyl)phenyl]-8-(hydroxymethyl)-2-oxo-N-propyl-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

(6R,7S,8R)-7-[4-(3-cyclopentylprop-1-ynyl)phenyl]-8-(hydroxymethyl)-2-oxo-N-propyl-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

C25H33N3O3 (423.2522)


   

(6S,7R,8R)-7-[4-(3-cyclopentylprop-1-ynyl)phenyl]-8-(hydroxymethyl)-2-oxo-N-propyl-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

(6S,7R,8R)-7-[4-(3-cyclopentylprop-1-ynyl)phenyl]-8-(hydroxymethyl)-2-oxo-N-propyl-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

C25H33N3O3 (423.2522)


   

(6R,7R,8R)-7-[4-(3-cyclopentylprop-1-ynyl)phenyl]-8-(hydroxymethyl)-2-oxo-N-propyl-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

(6R,7R,8R)-7-[4-(3-cyclopentylprop-1-ynyl)phenyl]-8-(hydroxymethyl)-2-oxo-N-propyl-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

C25H33N3O3 (423.2522)


   

2-cyclopropyl-1-[(1S)-2-(cyclopropylmethyl)-1-(hydroxymethyl)-7-methoxy-9-methyl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]yl]ethanone

2-cyclopropyl-1-[(1S)-2-(cyclopropylmethyl)-1-(hydroxymethyl)-7-methoxy-9-methyl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]yl]ethanone

C25H33N3O3 (423.2522)


   

(6R,7R,8S)-7-[4-(1-cyclohexenyl)phenyl]-N-cyclopentyl-8-(hydroxymethyl)-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

(6R,7R,8S)-7-[4-(1-cyclohexenyl)phenyl]-N-cyclopentyl-8-(hydroxymethyl)-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

C25H33N3O3 (423.2522)


   

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] (Z)-tetradec-9-enoate

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] (Z)-tetradec-9-enoate

C19H38NO7P (423.2386)


   

cis-5-(6-(1,3-Dioxan-2-YL)hexyl)-trans-4-formyl-2,ref.-3-diphenylisoxazolidine

cis-5-(6-(1,3-Dioxan-2-YL)hexyl)-trans-4-formyl-2,ref.-3-diphenylisoxazolidine

C26H33NO4 (423.2409)


   
   

LysoPE(0:0/14:1(9Z))

LysoPE(0:0/14:1(9Z))

C19H38NO7P (423.2386)


   

1-(9Z-tetradecenoyl)-glycero-3-phosphoethanolamine

1-(9Z-tetradecenoyl)-glycero-3-phosphoethanolamine

C19H38NO7P (423.2386)


   

pravastatin(1-)

pravastatin(1-)

C23H35O7 (423.2383)


A monocarboxylic acid anion resulting from the deprotonation of the carboxylic acid group of pravastatin.

   

ST 24:6;O2;Gly

ST 24:6;O2;Gly

C26H33NO4 (423.2409)


   

(4e,7s)-n-[(2e)-3-chloro-2-[(5s)-2,5-dimethyl-6-oxocyclohex-1-en-1-yl]prop-2-en-1-yl]-7-methoxydodec-4-enimidic acid

(4e,7s)-n-[(2e)-3-chloro-2-[(5s)-2,5-dimethyl-6-oxocyclohex-1-en-1-yl]prop-2-en-1-yl]-7-methoxydodec-4-enimidic acid

C24H38ClNO3 (423.254)


   

6-hydroxy-9-(2-methylbut-3-en-2-yl)-4-(2-methylpropyl)-16-propanoyl-2,5,16-triazatetracyclo[7.7.0.0²,⁷.0¹⁰,¹⁵]hexadeca-5,10,12,14-tetraen-3-one

6-hydroxy-9-(2-methylbut-3-en-2-yl)-4-(2-methylpropyl)-16-propanoyl-2,5,16-triazatetracyclo[7.7.0.0²,⁷.0¹⁰,¹⁵]hexadeca-5,10,12,14-tetraen-3-one

C25H33N3O3 (423.2522)


   

1-[(2r,6s)-6-[4-(4-hydroxyphenyl)-2-oxobutyl]piperidin-2-yl]-4-(4-methoxyphenyl)butan-2-one

1-[(2r,6s)-6-[4-(4-hydroxyphenyl)-2-oxobutyl]piperidin-2-yl]-4-(4-methoxyphenyl)butan-2-one

C26H33NO4 (423.2409)


   

(2s,4z)-5-hydroxy-4-[(2e,4e,6e,8r,10r)-1-hydroxy-6,8,10-trimethyldodeca-2,4,6-trien-1-ylidene]-2-[(4-hydroxyphenyl)methyl]-2h-pyrrol-3-one

(2s,4z)-5-hydroxy-4-[(2e,4e,6e,8r,10r)-1-hydroxy-6,8,10-trimethyldodeca-2,4,6-trien-1-ylidene]-2-[(4-hydroxyphenyl)methyl]-2h-pyrrol-3-one

C26H33NO4 (423.2409)


   

5-hydroxy-2-[(4-hydroxyphenyl)methyl]-4-[(2e,4e,6e,8r,10r)-6,8,10-trimethyldodeca-2,4,6-trienoyl]-1,2-dihydropyrrol-3-one

5-hydroxy-2-[(4-hydroxyphenyl)methyl]-4-[(2e,4e,6e,8r,10r)-6,8,10-trimethyldodeca-2,4,6-trienoyl]-1,2-dihydropyrrol-3-one

C26H33NO4 (423.2409)


   

n-[3-chloro-2-(6-oxocyclohex-1-en-1-yl)prop-2-en-1-yl]-7-methoxytetradec-4-enimidic acid

n-[3-chloro-2-(6-oxocyclohex-1-en-1-yl)prop-2-en-1-yl]-7-methoxytetradec-4-enimidic acid

C24H38ClNO3 (423.254)


   

(4e,7s)-n-[(2z)-3-chloro-2-(6-oxocyclohex-1-en-1-yl)prop-2-en-1-yl]-7-methoxytetradec-4-enimidic acid

(4e,7s)-n-[(2z)-3-chloro-2-(6-oxocyclohex-1-en-1-yl)prop-2-en-1-yl]-7-methoxytetradec-4-enimidic acid

C24H38ClNO3 (423.254)


   

(4z)-5-hydroxy-4-[(2e,4e,6e,8r,10r)-1-hydroxy-6,8,10-trimethyldodeca-2,4,6-trien-1-ylidene]-2-[(4-hydroxyphenyl)methyl]-2h-pyrrol-3-one

(4z)-5-hydroxy-4-[(2e,4e,6e,8r,10r)-1-hydroxy-6,8,10-trimethyldodeca-2,4,6-trien-1-ylidene]-2-[(4-hydroxyphenyl)methyl]-2h-pyrrol-3-one

C26H33NO4 (423.2409)


   

5-hydroxy-4-(1-hydroxy-6,8,10-trimethyldodeca-2,4,6-trien-1-ylidene)-2-[(4-hydroxyphenyl)methyl]-2h-pyrrol-3-one

5-hydroxy-4-(1-hydroxy-6,8,10-trimethyldodeca-2,4,6-trien-1-ylidene)-2-[(4-hydroxyphenyl)methyl]-2h-pyrrol-3-one

C26H33NO4 (423.2409)


   

(4e,7s)-n-[(2e)-3-chloro-2-(6-oxocyclohex-1-en-1-yl)prop-2-en-1-yl]-7-methoxytetradec-4-enimidic acid

(4e,7s)-n-[(2e)-3-chloro-2-(6-oxocyclohex-1-en-1-yl)prop-2-en-1-yl]-7-methoxytetradec-4-enimidic acid

C24H38ClNO3 (423.254)


   

n-[3-chloro-2-(2,5-dimethyl-6-oxocyclohex-1-en-1-yl)prop-2-en-1-yl]-7-methoxydodec-4-enimidic acid

n-[3-chloro-2-(2,5-dimethyl-6-oxocyclohex-1-en-1-yl)prop-2-en-1-yl]-7-methoxydodec-4-enimidic acid

C24H38ClNO3 (423.254)


   

(1r,4s,7s,9r)-6-hydroxy-9-(2-methylbut-3-en-2-yl)-4-(2-methylpropyl)-16-propanoyl-2,5,16-triazatetracyclo[7.7.0.0²,⁷.0¹⁰,¹⁵]hexadeca-5,10,12,14-tetraen-3-one

(1r,4s,7s,9r)-6-hydroxy-9-(2-methylbut-3-en-2-yl)-4-(2-methylpropyl)-16-propanoyl-2,5,16-triazatetracyclo[7.7.0.0²,⁷.0¹⁰,¹⁵]hexadeca-5,10,12,14-tetraen-3-one

C25H33N3O3 (423.2522)


   

(4e,7s)-n-[(2e)-3-chloro-2-(2,5-dimethyl-6-oxocyclohex-1-en-1-yl)prop-2-en-1-yl]-7-methoxydodec-4-enimidic acid

(4e,7s)-n-[(2e)-3-chloro-2-(2,5-dimethyl-6-oxocyclohex-1-en-1-yl)prop-2-en-1-yl]-7-methoxydodec-4-enimidic acid

C24H38ClNO3 (423.254)


   

(7s)-n-[3-chloro-2-(6-oxocyclohex-1-en-1-yl)prop-2-en-1-yl]-7-methoxytetradec-4-enimidic acid

(7s)-n-[3-chloro-2-(6-oxocyclohex-1-en-1-yl)prop-2-en-1-yl]-7-methoxytetradec-4-enimidic acid

C24H38ClNO3 (423.254)